[go: up one dir, main page]

WO2013048169A3 - Method for preparing taxane derivatives - Google Patents

Method for preparing taxane derivatives Download PDF

Info

Publication number
WO2013048169A3
WO2013048169A3 PCT/KR2012/007885 KR2012007885W WO2013048169A3 WO 2013048169 A3 WO2013048169 A3 WO 2013048169A3 KR 2012007885 W KR2012007885 W KR 2012007885W WO 2013048169 A3 WO2013048169 A3 WO 2013048169A3
Authority
WO
WIPO (PCT)
Prior art keywords
docetaxel
preparing
taxane derivatives
specific structure
preparing taxane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/007885
Other languages
French (fr)
Other versions
WO2013048169A2 (en
Inventor
Young Min Kim
Seong Ho Kim
Jin Suk Cho
Moon Suk Kim
Jong Won Yoon
Ho Joon Choi
Jai Young Song
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Samyang Genexbio Corp
Original Assignee
Samyang Genexbio Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Genexbio Corp filed Critical Samyang Genexbio Corp
Priority to JP2014533210A priority Critical patent/JP5870197B2/en
Publication of WO2013048169A2 publication Critical patent/WO2013048169A2/en
Publication of WO2013048169A3 publication Critical patent/WO2013048169A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

There is provided a method for preparing docetaxel that is a taxane derivative, and more specifically, a method for preparing docetaxel in which since the docetaxel having high purity can be prepared at a high yield through a simple production method including preparing an intermediate having a specific structure of a steric configuration that is the same type as the docetaxel that is a final product from a taxane compound having a specific structure and then semi-synthesizing the docetaxel using them, the method is very suitable for industrial manufacturing.
PCT/KR2012/007885 2011-09-30 2012-09-28 Method for preparing taxane derivatives Ceased WO2013048169A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014533210A JP5870197B2 (en) 2011-09-30 2012-09-28 Method for producing taxane derivative

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110099780A KR101379694B1 (en) 2011-09-30 2011-09-30 Method for preparing taxane derivatives
KR10-2011-0099780 2011-09-30

Publications (2)

Publication Number Publication Date
WO2013048169A2 WO2013048169A2 (en) 2013-04-04
WO2013048169A3 true WO2013048169A3 (en) 2013-06-13

Family

ID=47996638

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/007885 Ceased WO2013048169A2 (en) 2011-09-30 2012-09-28 Method for preparing taxane derivatives

Country Status (3)

Country Link
JP (1) JP5870197B2 (en)
KR (1) KR101379694B1 (en)
WO (1) WO2013048169A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100255460B1 (en) * 1992-10-30 2000-05-01 자끄 사비나 Method for preparing taxane derivatives
KR100297197B1 (en) * 1992-10-05 2001-11-26 자끄 사비나 Manufacturing method of taxane derivative
US20040073044A1 (en) * 2002-05-10 2004-04-15 Sharma Arun Prakash Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
KR20080054986A (en) * 2006-12-14 2008-06-19 한미약품 주식회사 Method for preparing docetaxel and intermediates used therein

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100297197B1 (en) * 1992-10-05 2001-11-26 자끄 사비나 Manufacturing method of taxane derivative
KR100255460B1 (en) * 1992-10-30 2000-05-01 자끄 사비나 Method for preparing taxane derivatives
US20040073044A1 (en) * 2002-05-10 2004-04-15 Sharma Arun Prakash Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
KR20080054986A (en) * 2006-12-14 2008-06-19 한미약품 주식회사 Method for preparing docetaxel and intermediates used therein

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
QI, C. M. ET AL.: "A novel method to synthesize docetaxel and its isomer with high yields.", JOURNAL OF HETEROCYCLIC CHEMISTRY., vol. 42, no. 4, 2005, pages 679 - 684, XP002482597 *

Also Published As

Publication number Publication date
WO2013048169A2 (en) 2013-04-04
JP5870197B2 (en) 2016-02-24
KR101379694B1 (en) 2014-03-31
KR20130035466A (en) 2013-04-09
JP2014528408A (en) 2014-10-27

Similar Documents

Publication Publication Date Title
JOP20210065A1 (en) Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
TN2013000411A1 (en) Branched 3-phenylpropionic acid derivatives and the use thereof
TN2013000347A1 (en) Production method of optically active dihydrobenzofuran derivative
WO2013159081A3 (en) Methods of preparing para-xylene from biomass
WO2012163937A3 (en) Solid solutions of polyphenols
IL232912B (en) Method for the production of stretchable and deformable optical elements, and elements thus obtained
MY164371A (en) Method for preparing cysteine or a derivative thereof using a novel o-phosphoserine sulfhydrylase
HK1259594A1 (en) Method for manufacturing a decorative piece
WO2012150606A3 (en) A process for preparing stable polymophic form of erlotinib hydrochloride
EP2852276B8 (en) Method of manufacturing a plant receptacle as well as a plant receptacle
MX2014004083A (en) Method of isolating ingenol.
EP4289819A3 (en) Process for the preparation of enantiomerically enriched 3-aminopiperidine
EP2883870B8 (en) Method for producing 1,4-benzoxazine compound
PL2797863T3 (en) Process for the production of 1,3-butadiene
WO2012115402A3 (en) Crystalline form of docetaxel and process for preparation thereof
WO2012044043A3 (en) Novel method of preparing benzoimidazole derivatives
EP2892886B8 (en) Process for the production of furan derivatives
WO2014009204A8 (en) Oxasilacycles and method for the production thereof
WO2013092672A3 (en) Method for recombinant production of labyrinthopeptins and functional derivatives thereof
WO2012134103A3 (en) Norbornene-ester-based derivative, method for preparing same, and uses thereof
MX343856B (en) Method for producing 1-h-pyrrolidine-2,4-dione derivatives.
WO2013135248A3 (en) Production of stabilized channel type cyclodextrin crystals
WO2012107445A3 (en) Soft substrate for cell culture and process for preparing the same
WO2013046233A3 (en) Process for the preparation of octreotide acetate
WO2013048169A3 (en) Method for preparing taxane derivatives

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2014533210

Country of ref document: JP

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 12834676

Country of ref document: EP

Kind code of ref document: A2